News, MEdia & events
Discover more about PPTA. Stay up to date with events, or click here to read recent press releases and more.



Calendar
Bleeding Disorders Awareness Month
Bleeding Disorders Awareness Month
Hemophilia Federation of America (HFA) Symposium
Hemophilia Federation of America (HFA) Symposium
National Primary Immunodeficiency Awareness Month
National Primary Immunodeficiency Awareness Month
American Academy of Neurology (AAN) Annual Meeting
American Academy of Neurology (AAN) Annual Meeting
2025 Clinical Immunology Society (CIS) Annual Meeting
2025 Clinical Immunology Society (CIS) Annual Meeting
Immunology 2025: Annual Meeting of the American Association of Immunologists
Immunology 2025: Annual Meeting of the American Association of Immunologists
PPTA International Plasma Protein Congress
PPTA International Plasma Protein Congress
Alpha-1 National Conference
Alpha-1 National Conference
National Infusion Center Association (NICA) Annual Conference
National Infusion Center Association (NICA) Annual Conference
Bleeding Disorders Conference
Bleeding Disorders Conference
Immune Thrombocytopenia (ITP) Awareness Month
Immune Thrombocytopenia (ITP) Awareness Month
GBS|CIDP International Symposium
GBS|CIDP International Symposium
International Plasma Awareness Week (IPAW) 2025
International Plasma Awareness Week (IPAW) 2025
PPTA Plasma Protein Forum 2025
PPTA Plasma Protein Forum 2025
PPTA Business Forum 2025
PPTA Business Forum 2025
Immunoglobulin National Society (IgNS) Annual National Conference
Immunoglobulin National Society (IgNS) Annual National Conference
Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting
Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting
Alpha-1 Awareness Month
Alpha-1 Awareness Month
International Primary Immunodeficiencies Congress (IPIC) 2025
International Primary Immunodeficiencies Congress (IPIC) 2025
Neuroscience 2025
Neuroscience 2025
ESID EHA SIOPE Focused Symposium 2025, “The Interplay of Immunology & Haematology”
ESID EHA SIOPE Focused Symposium 2025, “The Interplay of Immunology & Haematology”
American Society of Hematology (ASH) Annual Meeting and Exposition
American Society of Hematology (ASH) Annual Meeting and Exposition
Multifocal Motor Neuropathy Awareness Month
Multifocal Motor Neuropathy Awareness Month
Media
Find out more about what we do and what’s important to our sector via our media resources. You can also check out our social media pages to keep up to date with current events.

Interview with Irene Saugar Gómez, Ph.D., Quality Assessor of biological human medicinal products with the Spanish Agency of Medicines and Medical Devices

PPTA President and CEO Anita Brikman speaks with Grifols Egypt CEO Dr. Magdy Amin

Oksana Muliarchuk - Director of a Ukrainian-Based Network of Plasma Centers

Thomas Kreil, Winner of the Hilfenaus Award

Watch our interview with Prof. Richard Knight as he shares valuable perspectives on immunoglobulins

Patient Stories presented by PPTA

PPTA New Website and Brand Launch

The Brussels Times Hosts Event at the European Parliament

Take a tour of a plasma donation center in Frankfurt, Germany
-%20Day%20One.webp)
2022 International Plasma Protein Congress (IPPC): Day One

The need for a policy change – Plasma donation
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day Two

Differentiating Plasma from Blood

U.S. Roundtable on Immunoglobulin Use

EU BTC revision – The socioeconomic benefits of plasma-derived medicines

Why is Donating Plasma Important?

Strengthening the EU Blood Directive for patients who need plasma-derived medicines

Meet Amber, a Teacher and Dedicated Plasma Donor

Europe needs to collect more plasma – Improving patient access to plasma-derived medicines

EU BTC revision – Facts about compensating plasma donors
.jpg)
Highlights from the April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
.jpg)
April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)

“Introduction to the Global Journey of Plasma" webinar

Presentation of the 2020 Robert W. Reilly Award

Presentation of the 2020 Joachim Hilfenhaus Award

Highlights from the EP roundtable event “Ensuring Appropriate Patient Access to PDMPs”

Keynote Address – Admiral Brett Giroir, MD, U.S. HHS Assistant Secretary for Health

Keynote Address – Stella Kyriakides, European Commissioner for Health and Food Safety

Combating COVID-19 Industry Spotlight: Kedrion

Patient Perspectives on COVID-19 and Access to Care

Experts on Coronavirus: The Virus, The Disease, Prevention and Treatment

Plasma: An Overview

Combating COVID-19 Industry Spotlight: Grifols

Combating COVID-19 Industry Spotlight: Emergent

Combating COVID-19 Industry Spotlight: CoVIg-19 Plasma Alliance

Welcome to the Global Plasma Summit

Plasma 101

Spotlight on Plasma Part One: Together We Are Stronger

Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products

PPTA webinar on unique patient access challenges to plasma-derived medicinal products in COVID times link

Thank you, plasma donors!

From PPTA: "Thank you, plasma donors!"

Prof. Lieven Annemans Speaks about the Value of Plasma-Derived Therapies

The Power of Plasma Donation - Hungarian

The Power of Plasma Donation - Spanish

The Power of Plasma Donation - Czech

The Power of Plasma Donation - German
.jpg)
The Power of Plasma Donation Animation - English

IPPC 2025 Set to Honor Two Decades of Progress Within a Critical Global Plasma Supply Chain

IPPC 2025 Set to Honor Two Decades of Progress Within a Critical Global Plasma Supply Chain

National and EU Stockpiling Requirements Do Not Ensure Equitable Access to Plasma-Derived Medicinal Products

National and EU Stockpiling Requirements Do Not Ensure Equitable Access to Plasma-Derived Medicinal Products

Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”

Plasma Protein Forum Prepares to “Taking Steps Toward a Better Tomorrow”

Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024

Sharing the Lifesaving Impact of Plasma Donation During International Plasma Awareness Week 2024

Monkeypox Virus and Plasma-derived Medicinal Products

Monkeypox Virus and Plasma-derived Medicinal Products

PPTA Welcomes EMA Regulatory Update on vCJD

PPTA Welcomes EMA Regulatory Update on vCJD

PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs

PPTA Welcomes Sharon Pearce as New Vice President, Lead of Government Affairs

PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU

PPTA Regards SoHO Adoption a Step Forward to Strengthen Donor Protection and Plasma Supply in the EU

Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence

Dr. Charlotte Cunningham-Rundles Wins 2024 Joachim Hilfenhaus Award for Immunology Excellence

PPTA Responds to SoHO Regulation Compromise

PPTA Responds to SoHO Regulation Compromise

PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy

PPTA’s New Staff Members Aim to Further Plasma Sector Innovation and Advocacy

Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)

Summary of the PPTA/FDA Liaison Meeting (November 8, 2023)

PPTA Statement on Issuance of the EU Critical Medicines List

PPTA Statement on Issuance of the EU Critical Medicines List

PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum

PPTA Statement and Reflection on the Quebec Biovigilance Committee’s 8th Biovigilance Forum

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation

PPTA Press Release on the EU Parliament's ENVI Committee Vote on the SoHO Regulation

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

Announcing PPTA’s New Global Chair

Announcing PPTA’s New Global Chair

Monkeypox Virus and Plasma Protein Therapies

Monkeypox Virus and Plasma Protein Therapies

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Weight Loss Monitoring

PPTA Statement on Review of Donor Weight Loss Monitoring

Statement on Update on Safety of Albumin

Statement on Update on Safety of Albumin

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Human Parvovirus PARV4 and plasma protein therapies

Human Parvovirus PARV4 and plasma protein therapies

Ebola Virus and Plasma Protein Therapies

Ebola Virus and Plasma Protein Therapies

PPTA Statement on MSM Donor Policy

PPTA Statement on MSM Donor Policy

Zika Virus and Plasma Protein Therapies

Zika Virus and Plasma Protein Therapies
.webp)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
.webp)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.webp)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies

A Note to U.S. Plasma Donors on the Spread of Coronavirus

A Note to U.S. Plasma Donors on the Spread of Coronavirus

PPTA Responds to The Guardian Article

PPTA Responds to The Guardian Article

PPTA Statement on FDA Guidance Documents

PPTA Statement on FDA Guidance Documents

PPTA Repeats Appeals for Plasma Donations

PPTA Repeats Appeals for Plasma Donations

New York and California recognize the importance of plasma donation

New York and California recognize the importance of plasma donation

Plasma Donors Should be Celebrated, not Denigrated

Plasma Donors Should be Celebrated, not Denigrated

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

Yes, you can donate source plasma after getting the COVID vaccine

Yes, you can donate source plasma after getting the COVID vaccine

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

PPTA Statement on Immunoglobulin Use to Meet Clinical Need

Human Plasma Donations Remain Important During COVID-19 Pandemic

Human Plasma Donations Remain Important During COVID-19 Pandemic

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

PPTA Responds to ProPublica Article

PPTA Responds to ProPublica Article

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Leadership Update – Amy Efantis

PPTA Leadership Update – Amy Efantis

PPTA Statement on the Ukraine Crisis

PPTA Statement on the Ukraine Crisis

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes World Hemophilia Day 2014

PPTA Recognizes World Hemophilia Day 2014

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

Ensuring Access to Medicines for Patients

Ensuring Access to Medicines for Patients

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes World Hemophilia Day–April 17, 2015

PPTA Recognizes World Hemophilia Day–April 17, 2015

Alabama Lowers Minimum Donation Age to 18

Alabama Lowers Minimum Donation Age to 18

PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Names Amy Efantis President & CEO

PPTA Names Amy Efantis President & CEO

Plasma-Derived Therapies Provide Significant Health Value Gain

Plasma-Derived Therapies Provide Significant Health Value Gain

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

EU Health Commissioner says plasma donation plays a vital role

EU Health Commissioner says plasma donation plays a vital role

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

Calling on EU Policymakers to Increase Plasma Donations

Calling on EU Policymakers to Increase Plasma Donations

Adoption of the EP report “EU Pharmaceutical Strategy”

Adoption of the EP report “EU Pharmaceutical Strategy”
Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation
Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation
Plasma is Life podcast series episode 2: U.S. Election 2020 Wrap-Up

Maximize Your Experience at the 20th International Plasma Protein Congress in Warsaw

Maximize Your Experience at the 20th International Plasma Protein Congress in Warsaw

Changing Minds, Changing Lives: The Importance of Raising Awareness for Plasma Donation

Changing Minds, Changing Lives: The Importance of Raising Awareness for Plasma Donation

The Value of PPTA Membership In An Evolving Industry: A Conversation with David Bell & Anita Brikman

The Value of PPTA Membership In An Evolving Industry: A Conversation with David Bell & Anita Brikman

The Problem with Mandatory Stockpiling of Plasma-Derived Medicines in the European Union

The Problem with Mandatory Stockpiling of Plasma-Derived Medicines in the European Union

Share Your #IPAW2024 Feedback

Share Your #IPAW2024 Feedback

IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors

IPAW Reflections: Words of Appreciation for the Lifesaving Impact of Plasma Donors

Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines

Voices of Health Professionals in Treating Patients with Plasma-Derived Medicines

IPAW In Focus: Prioritizing Donor Safety

IPAW In Focus: Prioritizing Donor Safety

Putting Advocacy In Action During IPAW and Beyond

Putting Advocacy In Action During IPAW and Beyond

Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients

Access to Plasma-Derived Medicines: A Lifesaving Resource for Patients

Share Powerful Stories During #IPAW2024

Share Powerful Stories During #IPAW2024

Decorate Your Space for #IPAW2024!

Decorate Your Space for #IPAW2024!

Stay Connected on Social Media During #IPAW2024

Stay Connected on Social Media During #IPAW2024

Visit PlasmaWeek.org for Free IPAW Resources and More!

Visit PlasmaWeek.org for Free IPAW Resources and More!

Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford

Navigating Challenges and Opportunities in the Plasma Protein Therapeutics Industry: A Discussion with Anita Brikman and Giles Platford

A Mid-Year Message from PPTA President and CEO Anita Brikman

A Mid-Year Message from PPTA President and CEO Anita Brikman
Sharing the Power of Plasma on Capitol Hill
Sharing the Power of Plasma on Capitol Hill

From Patient to Provider: Laura’s Story

From Patient to Provider: Laura’s Story

2023 Annual Report

2023 Annual Report

PPTA Unveils Program for IPPC 2024

PPTA Unveils Program for IPPC 2024

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine

Stepping Inside a Plasma Fractionation Plant: How Human Plasma Becomes Life-Saving Medicine
PPTA Podcast
Learn more about why Plasma is Life through our podcasts, featuring a wide range of experts.

Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation

Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation

Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University
PPTA EVENTS
Stay up to date with our events, where you can network with our huge community and get more involved in our activities.
PPTA International Plasma Protein Congress
The International plasma protein congress brings together policymakers, stakeholders, patient groups and industry in Europe to discuss the need to increase plasma collection, regulatory and policy developments, patient health and donor safety.
International Plasma Awareness Week (IPAW) 2025
Learn more about International Plasma Awareness Week, the importance of donating plasma, the patients and families who rely on plasma donation, and more.
PPTA Plasma Protein Forum 2025
The Plasma Protein Forum is the premier conference for the plasma protein therapeutics industry in North America. This annual event brings industry, policymakers, health care providers, scientists, and patients together to learn more about and discuss key developments and issues.
PPTA Business Forum 2025
The PPTA Business Forum is a member-only event, presented by the board of directors and staff to keep members better informed and more involved in PPTA activities.


ADVOCACY TOOLKITs
These toolkits provide a one-stop resource for patient groups and association members interested in plasma protein therapies. You may use this information to frame your own advocacy efforts, educate your constituents, and strengthen your communications.
International Plasma Awareness Week toolkit (IPAW)
As a joint initiative of the PPTA and its member companies, IPAW aims to raise global awareness about source plasma collection and recognize the invaluable contribution of plasma donors. This toolkit was designed to enable partners, affiliated organizations and the media with resources to create and publicize events, such as IPAW.
Social media kit
PPTA’s social media channels seek to inform the public and engage with policymakers and patient stakeholder organizations as we advocate for access to plasma protein therapies. This tool kit offers captions and easy-to-post social media nuggets to support this cause on the daily basis.
Plasma advocacy material
This toolkit provides a one-stop resource for patients interested in plasma protein therapies. Here, you can learn about PPTA's work in both Europe and the U.S. and connect with other patient groups and consumer organizations.